• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[甲状旁腺激素制剂]

[PTH preparations].

作者信息

Fukumoto Seiji

出版信息

Nihon Rinsho. 2015 Oct;73(10):1696-700.

PMID:26529932
Abstract

Parathyroid hormone(PTH) is essential for maintaining serum calcium level. PTH increases serum calcium partly by enhancing bone resorption. Therefore, persistent excessive actions of PTH result in cortical bone loss by increased bone resorption. In contrast, intermittent injections of PTH preparations increase trabecular bone mainly by enhancing bone formation. Teriparatide is a peptide with 34 amino acids corresponding to the N-terminal portion of PTH. Both once daily and once weekly subcutaneous injections of teriparatide are available in Japan. Teriparatide was shown to prevent vertebral fractures. In addition, once daily injections of teriparatide also reduce non-vertebral fractures. However, there still remain several unanswered questions about the precise mechanisms of actions of teriparatide preparations.

摘要

甲状旁腺激素(PTH)对于维持血清钙水平至关重要。PTH部分通过增强骨吸收来提高血清钙水平。因此,PTH持续过度作用会因骨吸收增加导致皮质骨丢失。相比之下,间歇性注射PTH制剂主要通过增强骨形成来增加小梁骨。特立帕肽是一种由34个氨基酸组成的肽,对应于PTH的N端部分。在日本,特立帕肽有每日一次和每周一次皮下注射两种剂型。特立帕肽已被证明可预防椎体骨折。此外,每日一次注射特立帕肽还可减少非椎体骨折。然而,关于特立帕肽制剂确切的作用机制仍有几个问题尚未得到解答。

相似文献

1
[PTH preparations].[甲状旁腺激素制剂]
Nihon Rinsho. 2015 Oct;73(10):1696-700.
2
The use of PTH in the treatment of osteoporosis.甲状旁腺激素在骨质疏松症治疗中的应用。
Arq Bras Endocrinol Metabol. 2010 Mar;54(2):213-9. doi: 10.1590/s0004-27302010000200018.
3
[Therapeutic agents for disorders of bone and calcium metabolism--Parathyroid hormone in weekly subcutaneous injection].[用于骨与钙代谢紊乱的治疗药物——每周一次皮下注射甲状旁腺激素]
Clin Calcium. 2007 Jan;17(1):56-62.
4
[Once-weekly teriparatide treatment on osteoporosis].[每周一次特立帕肽治疗骨质疏松症]
Clin Calcium. 2014 Jan;24(1):100-5.
5
New therapeutic targets for osteoporosis.骨质疏松症的新治疗靶点。
Maturitas. 2019 Feb;120:1-6. doi: 10.1016/j.maturitas.2018.11.010. Epub 2018 Nov 16.
6
Biologicals in osteoporosis: teriparatide and parathyroid hormone in women and men.骨质疏松症中的生物制剂:特立帕肽和甲状旁腺激素在女性和男性中的应用。
Curr Osteoporos Rep. 2010 Sep;8(3):154-61. doi: 10.1007/s11914-010-0024-1.
7
[Daily subcutaneous injection of teriparatide : the progress and current issues].[特立帕肽每日皮下注射:进展与当前问题]
Clin Calcium. 2014 Jan;24(1):35-43.
8
[Evidence in the treatment of osteoporosis using weekly teriparatide injections].[使用特立帕肽每周注射治疗骨质疏松症的证据]
Clin Calcium. 2012 Mar;22(3):407-13.
9
Mixed-treatment comparison of anabolic (teriparatide and PTH 1-84) therapies in women with severe osteoporosis.女性严重骨质疏松症的合成代谢(特立帕肽和 PTH 1-84)治疗的混合治疗比较。
Curr Med Res Opin. 2012 Mar;28(3):467-73. doi: 10.1185/03007995.2012.659724. Epub 2012 Feb 16.
10
Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal.在已确立的激素治疗基础上加用甲状旁腺激素:甲状旁腺激素撤药后对椎体骨折及骨量维持的影响。
J Bone Miner Res. 2001 May;16(5):925-31. doi: 10.1359/jbmr.2001.16.5.925.